| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Revenue | 154,211 | 139,098 | ||
| Cost of revenue | 28,012 | 41,335 | ||
| Gross profit | 126,199 | 97,763 | ||
| Research and development | 31,921 | 279,962 | ||
| Sales and marketing | 63,520 | 147,228 | ||
| General and administrative | 36,851 | 251,244 | ||
| Total operating expenses | 132,292 | 678,434 | ||
| Loss from operations | -6,093 | -580,671 | ||
| Other income, net | 4,455 | 4,694 | ||
| Net income (loss) before income taxes | -1,638 | -575,977 | ||
| Provision for income taxes | 206 | -326 | ||
| Net income (loss) | -1,844 | -575,651 | ||
| Adjustment to reflect deemed contribution from series d and series e redeemable convertible preferred stock extinguishment | 0 | 0 | ||
| Undistributed earnings attributable to participating securities | 0 | - | ||
| Net income (loss) attributable to common stockholders, basic | -1,844 | -575,651 | ||
| Earnings per share, basic | -0.02 | -13.1 | ||
| Earnings per share, diluted | -0.02 | -13.1 | ||
| Weighted average number of shares outstanding, basic | 78,858,000 | 43,931,000 | ||
| Weighted average number of shares outstanding, diluted | 78,858,000 | 43,931,000 | ||
Hinge Health, Inc. (HNGE)
Hinge Health, Inc. (HNGE)